Skip to content

Research on the Improvement of Musculoskeletal Joint Health in Middle-aged People by Compound Formula Milk Powder

Research on the Improvement of Musculoskeletal Joint Health in Middle-aged People by Compound Formula Milk Powder.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126719
Enrollment
Unknown
Registered
2026-06-15
Start date
2026-06-20
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis, sarcopenia, osteoarthritis

Interventions

Yili Xinhuo Bone Gold Assembly Formula Milk Powder Group:Yili Xinhuo Bone Gold Assembly Formula Milk Powder
Blank control group:none

Sponsors

Chinese Center for Disease Control and Prevention
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Age range: 40 to 60 years old. Woman are postmenopausal. 2.Routine physical examination results are normal. 3.There has been no significant change in weight over the past six months. 4.Body Mass Index (BMI) falls within the range of 18.5 - 27.9 kg/m²;

Exclusion criteria

Exclusion criteria: 1. Lactose intolerance or dairy allergy; 2. Having malignant tumors, diabetes, digestive system diseases, or liver and kidney dysfunction that affect protein and amino acid absorption; 3. Pregnant or breastfeeding women; 4. History of surgery in the past three months; 5. People who drink or smoke excessively (according to WHO, excessive drinking is daily alcohol intake >= 40g for men and >= 20g for women, sustained for over 5 years; excessive smoking is smoking for >= 10 years with an average of >= 15 cigarettes per day).

Design outcomes

Primary

MeasureTime frame
Muscle function evaluation indicators: calf circumference, skeletal muscle mass, grip strength, 6m walking speed, and chair stand test;Joint function: Human N-terminal mid-segment osteocalcin, type I collagen N-terminal propeptide, bone-specific alkaline phosphatase, human type I collagen C-terminal peptide, tartrate-resistant acid phosphatase;

Secondary

MeasureTime frame
SCFAs,Fecal short-chain fatty acids;Element content: serum calcium and phosphorus;BMD;PTH?CT;Gut microbiota;uCTX-II? COMP;Cytokines: IL-6, TNF-a, IL-1ß, IL-10, IL-4;Body weight and body composition;

Countries

China

Contacts

Public ContactLi Min

Chinese Center for Disease Control and Prevention

limin@ninh.chinacdc.cn+86 10 6623 7172

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026